Amantadine triple therapy for non-responder hepatitis C patients. Clues for controversies (ANRS HC 03 BITRI) - Vigipallia

0 avis

Amantadine triple therapy for non-responder hepatitis C patients. Clues for controversies (ANRS HC 03 BITRI)

Archive ouverte

Maynard, M. | Pradat, P. | Baily, F. | Rozier, F. | Nemoz, C. | Si Ahmed, S. | Adeleine, P. | Trepo, C.

Edité par CCSD ; Elsevier -

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatment

Archive ouverte | Pradat, P. | CCSD

Clinical relevance of total HCV Core antigen testing for hepatitis C monitoring and for predicting patients` response to therapy

Archive ouverte | Maynard, M. | CCSD

Prevalence of hepatitis C infection among general practice patients in the Lyon area France

Archive ouverte | Pradat, P. | CCSD

Chargement des enrichissements...